Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
Ho CY, López B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, González A, Colan SD, Seidman JG, Díez J, Seidman CN Engl J Med. 2010 Aug 5;363(6):552-63. doi: 10.1056/NEJMoa1002659.
Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ.
Circulation. 2010 Jan 26;121(3):445-56. doi: 1
Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes.
Anastasakis A, Kotsiopoulou C, Rigopoulos A, Theopistou A, Protonotarios N, Panagiotakos D, Mammalis N, Stefanadis C.
Heart. 2005 Nov;91(11):1477-8.
http://heart.bmj.com/content/91/11/1477.long
Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, Lever HM.
Circulation. 2013 Jul 16;128(3):209-16.
Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP, Syrris P, Esteban MT, Jenkins S, Pantazis A, Deanfield JE, McKenna WJ, Elliott PM.
Circ Cardiovasc Genet. 2009 Oct;2(5):436-41.
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ.
Circulation. 2011 Jul 5;124(1):40-7.
Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Gimeno JR, Tomé-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B, Lambiase P, McKenna WJ, Elliott PM.
Eur Heart J. 2009 Nov;30(21):2599-605.
Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.
Anastasakis A, Theopistou A, Rigopoulos A, Kotsiopoulou C, Georgopoulos S, Fragakis K, Sevdalis E, Stefanadis C.
Hellenic J Cardiol. 2013 Jul-Aug;54(4):281-8.
Syncope and risk of sudden death in hypertrophic cardiomyopathy.
Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barillà CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ.
Recommendations for the cardiovascular screening of athletes.
Deligiannis A, Anastasakis A, Antoniades L, Bobotis G, Geleris P, Goudevenos J, Hahalis G, Kouidi E, Kranidis A, Kremastinos D, Lekakis J, Parcharidis G, Pyrgakis V, Rontogiannis G, Stefanadis C, Styliadis I, Vardas P.
Hellenic J Cardiol. 2010 Nov-Dec;51(6):530-7.
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ.
Recommendations for interpretation of 12-lead electrocardiogram in the athlete.
Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bjørnstad HH, Carrè F, Deligiannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes NA 3rd, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ; Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation.
Eur Heart J. 2010 Jan;31(2):243-59. doi: 10.1093/eurheartj/ehp473. Epub 2009 Nov 20.
http://www.ncbi.nlm.nih.gov/pubmed/19933514
Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, Lever HM.
Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, Lever HM.
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G; Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
Eur Heart J. 2005 Mar;26(5):516-24. Epub 2005 Feb 2
Prognostic value of right ventricular diastolic function indices in hypertrophic cardiomyopathy.
Pagourelias ED, Efthimiadis GK, Parcharidou DG, Gossios TD, Kamperidis V, Karoulas T, Karvounis H, Styliadis IH
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ.
Circulation. 2008 Oct 7;118(15):1541-9.
Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm formation in a single family: case report.
Efthimiadis GK, Pliakos C, Pagourelias ED, Parcharidou DG, Spanos G, Paraskevaidis S, Styliadis IH, Parcharidis G.
Normal systolic function in hypertrophic cardiomyopathy: reality or myth?
Efthimiadis GK, Meditskou S, Giannakoulas G, Parcharidou D, Styliadis I, Mochlas S, Parcharidis GE.
Athletes with repolarization abnormalities.
Efthimiadis GK, Meditskou S, Parcharidis GE.
A patient with ventricular tachycardia due to a novel mutation of the lamin A/C gene: case presentation and mini review.
Kourgiannidis G, Anastasakis A, Lampropoulos K, Iliopoulos T.
Hellenic J Cardiol. 2013 Jul-Aug;54(4):326-30.
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy.
van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, Dooijes D, van den Berg MP.
Peripartum Cardiomyopathy.
Okeke T, Ezenyeaku C, Ikeako L.
Ann Med Health Sci Res. 2013 Jul;3(3):313-319.
Prevalence of desmin mutations in dilated cardiomyopathy.
Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, Haubold K, Boucek MM, Ferguson D, Graw SL, Zhu X, Cavanaugh J, Sucharov CC, Long CS, Bristow MR, Lavori P, Mestroni L; Familial Cardiomyopathy Registry; BEST (Beta-Blocker Evaluation of Survival Trial) DNA Bank.
Prevalence of desmin mutations in dilated cardiomyopathy.
Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, Haubold K, Boucek MM, Ferguson D, Graw SL, Zhu X, Cavanaugh J, Sucharov CC, Long CS, Bristow MR, Lavori P, Mestroni L; Familial Cardiomyopathy Registry; BEST (Beta-Blocker Evaluation of Survival Trial) DNA Bank.
Circulation. 2007 Mar 13;115(10):1244-51. Epub 2007 Feb 26.
Dilated cardiomyopathy with conduction disease and arrhythmia.
Lakdawala NK, Givertz MM.
Circulation. 2010 Aug 3;122(5):527-34.
Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
Lakdawala NK, Dellefave L, Redwood CS, Sparks E, Cirino AL, Depalma S, Colan SD, Funke B, Zimmerman RS, Robinson P, Watkins H, Seidman CE, Seidman JG, McNally EM, Ho CY.
J Am Coll Cardiol. 2010 Jan 26;55(4):320-9. doi: 10.1016/j.jacc.2009.11.017
Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonance.
Quarta G, Husain SI, Flett AS, Sado DM, Chao CY, Tomé Esteban MT, McKenna WJ, Pantazis A, Moon JC.
J Cardiovasc Magn Reson. 2013 Feb 11;15:16. doi: 10.1186/1532-429X-15-16
Arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Avramides D, Protonotarios N, Asimaki A, Matsakas E.
Hellenic J Cardiol. 2011 Sep-Oct;52(5):452-61
Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.
Asimaki A, Tandri H, Duffy ER, Winterfield JR, Mackey-Bojack S, Picken MM, Cooper LT, Wilber DJ, Marcus FI, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Stevenson WG, McKenna WJ, Gautam S, Remick DG, Calkins H, Saffitz JE.
Circ Arrhythm Electrophysiol. 2011 Oct;4(5):743-52.
Images in cardiovascular medicine. Imaging of arrhythmogenic right ventricular cardiomyopathy.
Winkens MH, Snoep G, Bekkers SC.
Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.
Asimaki A, Tandri H, Duffy ER, Winterfield JR, Mackey-Bojack S, Picken MM, Cooper LT, Wilber DJ, Marcus FI, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Stevenson WG, McKenna WJ, Gautam S, Remick DG, Calkins H, Saffitz JE
A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.
Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, McKenna WJ, Calkins H, Saffitz JE.
Author information
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI.
Circulation. 2010 Sep 21;122(12):1144-52.
Naxos disease: cardiocutaneous syndrome due to cell adhesion defect.
Protonotarios N, Tsatsopoulou A.
Orphanet J Rare Dis. 2006 Mar 13;1:4.
Arrhythmogenic right ventricular dysplasia, a cell adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype--phenotype assessment.
Tsatsopoulou AA, Protonotarios NI, McKenna WJ.
Heart. 2006 Dec;92(12):1720-3.
Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria.
Quarta G, Muir A, Pantazis A, Syrris P, Gehmlich K, Garcia-Pavia P, Ward D, Sen-Chowdhry S, Elliott PM, McKenna WJ.
Circulation. 2011 Jun 14;123(23):2701-9.
Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy.
Quarta G, Syrris P, Ashworth M, Jenkins S, Zuborne Alapi K, Morgan J, Muir A, Pantazis A, McKenna WJ, Elliott PM.
The ECG in arrhythmogenic right ventricular cardiomyopathy: ε-waves and anterior T-wave inversion.
O'Mahony C, Cauti FM, Pantazis A.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study.
Cox MG, van der Zwaag PA, van der Werf C, van der Smagt JJ, Noorman M, Bhuiyan ZA, Wiesfeld AC, Volders PG, van Langen IM, Atsma DE, Dooijes D, van den Wijngaard A, Houweling AC, Jongbloed JD, Jordaens L, Cramer MJ, Doevendans PA, de Bakker JM, Wilde AA, van Tintelen JP, Hauer RN.
Mutational heterogeneity, modifier genes, and environmental influences contribute to phenotypic diversity of arrhythmogenic cardiomyopathy.
Sen-Chowdhry S, Syrris P, Pantazis A, Quarta G, McKenna WJ, Chambers JC.
Circ Cardiovasc Genet. 2010 Aug;3(4):323-30.
Arrhythmogenic left ventricular cardiomyopathy.
Coats CJ, Quarta G, Flett AS, Pantazis AA, McKenna WJ, Moon JC.
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W.
Circulation. 2010 Apr 6;121(13):1533-41.
Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations.
Protonotarios N, Anastasakis A, Antoniades L, Chlouverakis G, Syrris P, Basso C, Asimaki A, Theopistou A, Stefanadis C, Thiene G, McKenna WJ, Tsatsopoulou A.
Left ventricular noncompaction cardiomyopathy: an overdiagnosed disease.
Niemann M, Störk S, Weidemann F.
Images in cardiology. Hypertrophic cardiomyopathy and left ventricular hypertrabeculation: evidence for an overlapping phenotype.
Pantazis AA, Kohli SK, Elliott PM.
Heart. 2006 Mar;92(3):349.
Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?
Kohli SK, Pantazis AA, Shah JS, Adeyemi B, Jackson G, McKenna WJ, Sharma S, Elliott PM.
Eur Heart J. 2008 Jan;29(1):89-95.
Sarcomere mutations in cardiomyopathy, noncompaction, and the developing heart.
Dellefave L, McNally EM.
Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy.
Kelley-Hedgepeth A, Towbin JA, Maron MS.
Circulation. 2009 Jun 16;119(23):e588-9.